AshwinPatkarMDMRCPsych, DFASAM

PubMed

• Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting.
  Kyung Ho Lee, Tae Sun Han, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand, Chi-Un Pae> ;Clinical Psychopharmacology and Neuroscience. 2023 Aug 31
• 5 citations
  Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial.
  Cheolmin Shin, Sang Won Jeon, Seung-Hoon Lee, Chi-Un Pae, Narei Hong, Hyun Kook Lim, Ashwin A Patkar, Prakash S Masand, Hyonggin An, Changsu Han> ;Clinical Psychopharmacology and Neuroscience. 2023 Feb 28
• Investigating the effectiveness of a smart mental health intervention (inMind) for stress reduction during pharmacological treatment for mild to moderate major depress...
  Junhyung Kim, Cheolmin Shin, Kyu-Man Han, Moon-Soo Lee, Hyun-Ghang Jeong, Chi-Un Pae, Ashwin A Patkar, Prakash M Masand, Changsu Han> ;Frontiers in Psychiatry. 2023 Jan 1
• 2 citations
  Rapastinel accelerates loss of withdrawal signs after repeated morphine and blunts relapse to conditioned place preference.
  Christopher Armstrong, Julia Ferrante, Nidesh Lamichhane, Zachery Reavis, David Walker, Ashwin Patkar, Cynthia Kuhn> ;Pharmacology, Biochemistry, and Behavior. 2022 Nov 1
• Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Co...
  Seung-Hoon Lee, Sang Won Jeon, Cheolmin Shin, Chi-Un Pae, Ashwin A Patkar, Prakash S Masand, Hyonggin An, Changsu Han> ;Psychiatry Investigation. 2022 Jun 1
• 4 citations
  Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Co...
  Seung-Hoon Lee, Sang Won Jeon, Cheolmin Shin, Chi-Un Pae, Ashwin A Patkar, Prakash S Masand, Hyonggin An, Changsu Han> ;Psychiatry Investigation. 2022 Apr 1
• 5 citations
  Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia.
  Jung-Jin Kim, Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A Patkar, Prakash S. Masand> ;Clinical Psychopharmacology and Neuroscience. 2021 Nov 30
• 7 citations
  Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?
  Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A Patkar, Prakash S. Masand> ;Clinical Psychopharmacology and Neuroscience. 2021 Aug 31
• 3 citations
  Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder.
  Cheolmin Shin, Chi-Un Pae, Kyung Phil Kwak, Sang Won Jeon, Hyun Ghang Jeong, Jong Woo Kim, Youn Jung Lee, Ashwin A. Patkar, Changsu Han> ;Clinical Psychopharmacology and Neuroscience. 2021 May 31
• 1 citations
  Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patient...
  Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand> ;Clinical Psychopharmacology and Neuroscience. 2021 May 31
• 2 citations
  Possible Modulatory Role of ARC Gene Variants in Mood Disorders.
  Concetta Crisafulli, Marco Calabrò, Laura Mandelli, Sheng-Min Wang, Soo-Jung Lee, Changsu Han, Ashwin A Patkar, Prakash S. Masand, Chi-Un Pae, Daniel Souery, Julien Me...> ;Clinical Psychopharmacology and Neuroscience. 2021 Feb 28
• 13 citations
  Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD): A Randomized, Double-Blind, Placebo-Controlled Trial.
  S. Nassir Ghaemi, Elizabeth A. Whitham, Paul A. Vöhringer, Sergio Barroilhet, Andrea Amerio, Oleksandr Sverdlov, Ashwin A. Patkar> ;The Journal of Clinical Psychiatry. 2021 Jan 12
• 2 citations
  SBIRT training: how do social work students compare to medical learners?
  Matthew P Martin, Summer G Woodside, Chong Lee, Laura Henry, Ashwin Patkar> ;Social Work in Health Care. 2021 Jan 1
• 1 citations
  Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical ...
  Changsu Han, Sheng-Min Wang, Won-Myong Bahk, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand, Laura Mandelli, Chi-Un Pae, Alessandro Serretti> ;Clinical Psychopharmacology and Neuroscience. 2020 Nov 30
• 8 citations
  Reduced plasma Fetuin-A is a promising biomarker of depression in the elderly
  Giuseppe Fanelli, Francesco Benedetti, Sheng Min Wang, Soo-Jung Lee, Tae Youn Jun, Prakash S. Masand, Ashwin A. Patkar, Changsu Han, Alessandro Serretti, Chi-Un Pae, C...> ;European Archives of Psychiatry and Clinical Neuroscience. 2020 Oct 1
• 27 citations
  Comparative efficacy and acceptability of pharmacological interventions for the treatment and prevention of delirium: A systematic review and network meta-analysis.
  Hye Chang Rhim, Ariel Park, Hanna Kim, Kyu Man Han, Ashwin A. Patkar, Chi-Un Pae, Changsu Han> ;Journal of Psychiatric Research. 2020 Jun 1
• 22 citations
  A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection.
  Rae Jean Proeschold-Bell, Donna M. Evon, Jia Yao, Donna Niedzwiecki, Christina Makarushka, Kelly A. Keefe, Ashwin A. Patkar, Paolo Mannelli, James C. Garbutt, John B. ...> ;Hepatology. 2020 Jun 1
• 4 citations
  ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders
  Marco Calabrò, Laura Mandelli, Concetta Crisafulli, Marco Di Nicola, Roberto Colombo, Luigi Janiri, Soo-Jung Lee, Tae Youn Jun, Sheng Min Wang, Prakash S. Masand, Ashw...> ;Clinical Psychopharmacology and Neuroscience. 2020 May 31
• 14 citations
  Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature.
  Jonathan R Young, Shayan A Smani, Nicholas A. Mischel, Michael D. Kritzer, Lawrence G. Appelbaum, Ashwin A. Patkar> ;Journal of Addictive Diseases. 2020 Mar 17
• 7 citations
  Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patient...
  Chi-Un Pae, Changsu Han, Won Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand> ;Clinical Psychopharmacology and Neuroscience. 2020 Feb 29
• 9 citations
  The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study.
  Changsu Han, Sheng Min Wang, Won Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand, Chi-Un Pae> ;Clinical Psychopharmacology and Neuroscience. 2019 Nov 20
• 2 citations
  Updates on Preclinical and Translational Neuroscience of Mood Disorders: A Brief Historical Focus on Ketamine for the Clinician.
  Nicholas A. Mischel, Michael D. Kritzer, Ashwin A. Patkar, Prakash S. Masand, Steven T. Szabo> ;Journal of Clinical Psychopharmacology. 2019 Nov 1
• 1 citations
  Corrigendum: Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: An expert consensus (CNS Spectrums (2018) 23:6 (40...
  Kevin J. Black, Henry Nasrallah, Stuart Isaacson, Mark Stacy, Rajesh Pahwa, Charles H. Adler, Gustavo Alva, Jeffrey W. Cooney, Daniel Kremens, Matthew Menza, Johnathan...> ;CNS Spectrums. 2019 Oct 1
• 12 citations
  Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1.
  Marco Calabrò, Laura Mandelli, Concetta Crisafulli, Soo-Jung Lee, Tae Youn Jun, Sheng Min Wang, Ashwin A. Patkar, Prakash S. Masand, Changsu Han, Chi-Un Pae, Alessandr...> ;Clinical Psychopharmacology and Neuroscience. 2019 Aug 31
• 8 citations
  Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression
  Giuseppe Fanelli, Francesco Benedetti, Sheng Min Wang, Soo-Jung Lee, Tae Youn Jun, Prakash S. Masand, Ashwin A. Patkar, Changsu Han, Alessandro Serretti, Chi-Un Pae, C...> ;Journal of Affective Disorders. 2019 Apr 15
• Join now to see all

Journal Articles

• Vitamin D deficiency and psychiatric illness  
  Harris HW, Jaiswal P, Holmes V, Weisler RH, Patkar AA, Current Psychiatry, 1/1/2013
• Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder  
  Crisafulli C, Shim DS, Andrisano C, Pae CU, Chiesa A, Han C, Patkar AA, Lee SJ, Serretti A, De Ronchi D, Psychiatry Res, 1/2/2012
• Influence of BDNF cariants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia  
  Pae CU, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, Park MH, Serretti A, De Ronchi D, Neuropsychobiology, 1/1/2012
• Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variations rs10042486 on schizophrenia and response to antipsychotics  
  Crisafulli C, Chiesa A, Han C, Lee SJ, Park MH, Balzarro B, Andrisano C, Patkar AA, Pae CU, Serretti A, Eur Arch Psychiatry Clin Neurosci, 1/1/2012
• An integrated alcohol abuse and medical treatment model for patients with hepatitis C  
  Proeschold-Bell RJ, Patkar AA, Naggie S, Coward L, Mannelli P, Yao J, Bixby P, Muir AJ, Dig Dis Sci, 1/1/2012
• The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal  
  Mannelli P, Peindl K, Wu LT, Patkar AA, Gorelick DA, AM J Drug Alcohol Abuse, 1/1/2012
• Predictors of Response to Ziprasidone: Results from a 6-Week Randomized Double-Blind, Placebo-Controlled Trial for Acute depressive Mixed State  
  Pae CU, Patkar AA, Gilmer W, Holtzman N, Thommi SB, Ghaemi SN, Pharmacopsychiatry, 1/1/2012
• DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder  
  Chiesa A, Pae CU, Procelli S, Han C, Lee SJ, Patkar AA, Park MH, Jun TY, Serretti A, J Int Med Res, 1/1/2012
• A review of clinical trial data and clinical implications  
  Wang SM, Han C, Lee SJ, Patkar AA, Pae CU, Fleischhacker WW Paliperidone, Clin Drug Investig, 1/1/2012
• Influence of GRIA1, GRIA2, and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder  
  Chiesa A, Crisafulli C, Porcelli S, Han C, Patkar AA, Lee SJ, Park MH, Jun TY, Serretti A, Pae CU, Eur Arch Psychiatry Clin Neurosci, 1/5/2011
• HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study  
  Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, Connery HS, Woody GE, Acquir Immune Defic Syndr, 1/1/2010
• Paroxetine mesylate: comparable to paroxetine hydrochloride? Expert Opin Pharmacother  
  Pae CU, Misra A, Ham BJ, Han C, Patkar AA, Masand PS, Expert Opin Pharmacother, 1/1/2010
• Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study  
  Kane JM, D'Souza DC, Patkar AA, Youakim JM, Tiller JM, Yang R, Keefe RS, Clin Psychiatry, 1/1/2010
• A randomized, double-blind, placebo-controlled trial of controlled release paroxetine in Irritable Bowel Syndrome  
  Masand PS, Pae CU, Krulewicz S, Peindl K, Mannelli P, Varia I, Patkar AA, Psychosomatic Medicine, 1/1/2009
• Short-, intermediate-, and long-term outcomes of Pennsylvania's continuum of tobacco education pilot project  
  Leone FT, Evers-Casey S, Veloski J, Patkar AA, Kanzleiter L, Pennsylvania continuum of tobacco education work shop, Nicotine and Tobacco Research, 1/1/2009
• History of early abuse as a predictor of treatment response in patients with fibromyalgia: post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled...  
  Pae CU, Masand PS, Marks DM, Krulewicz S, Han C, Peindl K, Mannelli P, Patkar AA, World J Biol Psychiatry, 1/1/2009
• Methylphenidate extended release (OROS MPH) for the treatment of antidepressant- related sexual dysfunction in patients with treatment-resistant depression: results fr...  
  Pae CU, Marks DM, Masand PS, Peindl K, Hooper-Wood C, Han C, Mannelli P, Ciccone P, Patkar AA, Clin Neuropharmacol, 1/1/2009
• Opioid use affects antioxidant activity and purine metabolism: preliminary results  
  Mannelli P, Patkar AA, Rozen S, Matson W, Krishnan R, Kaddurah-Daouk R, Human Psychopharmacology, 1/1/2009
• Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain  
  Langley PC, Patkar AA, Boswell KA, Benson CJ, Schein JR, Curr Med Res Opin, 1/1/2009
• Psychometric properties of the patient Health Questionnaire- 15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients  
  Han C, Pae CU, Patkar AA, Masand PS, Kim KW, Joe SH, Jung IK, Psychosomatics, 1/1/2009
• Diagnosis and Treatment of Opioid Dependence  
  Patkar AA, Bhatia K, Lee J, BMJ Point of Care, 1/1/2009
• Paroxetine for patients with undifferentiated somatoform disorder: A prospective, open-label, 8-week pilot study  
  Han C, Marks DM , Pae CU, Lee BH, Ko YH, Masand PS, Patkar AA, Jung IK, Current Therapeutic Research, 1/1/2008
• Triple reuptake inhibitors: the next generation of antidepressants  
  Marks DM, Pae CU, Patkar AA, Current Neuropharmacology, 1/1/2008
• An open label, rater-blinded, flexible-dose, 8-week trial of escitalopram in major depressive disorder  
  Pae CU, Masand PM, Peindl K, Han C, Marks D, Patkar AA, Prim Care Companion J Cl Psych, 1/1/2008
• The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double- blind, placebo-control...  
  Pae CU, Lim HK, Peindl K, Ajwani N, Serretti A, Patkar AA, Lee C, Int Clin Psychopharmacol, 1/1/2008
• Join now to see all

Books/Book Chapters

• Interventions for Addiction: Comprehensive Addictive Behaviors and Disorders 
  Chapter: Medication for Cravings in Substance Use Disorders 
  Page 527 - 542Patkar, A.A., Lee, J.C., Burgess, D.M.Editors: Miller P.Elsevier Inc., Academic Press, San Diego, CA2013
• Guide to Assessment Scales in Schizophrenia 
  Chapter: Rating Scales for Substance Abuse 
  Page 181 - 187Patkar AA & Lee JCEditors: Keefe R.Springer Health Care, New York, NY2012
• Pharmacology and Therapeutics. From Principles to Practice 
  Chapter: Neuropharmacology of Anxiety Disorders 
  Pae Chi-un and Patkar AAEditors: Waldman SA and Terzic A.Elsevier, New York, NY2008
• Textbook of Consultation-Liaison Psychiatry 
  Chapter: Mania, Catatonia, & Psychosis in the Medically Ill 
  Masand PS, Christopher E, Clary GS, Mago RM, Patkar AAAmerican Psychiatric Press, Washington, DC2004
• Join now to see all

Abstracts/Posters

• Serotonin transporter gene polymorphisms in cocaine dependence
  ll KP, Patkar AA, Berrettini WH, Gottheil E, Wendel B, Sterling RC and Weinstein SP, AMIS-PHL Student Poster Competition, Philadelphia, PA, 1/1/1999

Lectures

• Urinary concentrations of buprenorphine and norbuprenorphine as indicators of noncompliance and diversion. 
  Austin, TX - 1/23/2015
• Brain Music Therapy for insomnia and anxiety in Addiction Treatment. 
  Austin, TX - 1/23/2015
• Screening and Brief Intervention for substance abuse in patients with Hepatitis C. 
  Duke University Health Center - 1/18/2015
• Strategies for treatment of opioid addiction. 
  Raleigh, NC - 1/17/2015
• Resilience and Recovery in Substance Abuse Treatment. 
  Point Clear, AL - 1/15/2015
• Screening and Brief Intervention training for students and Professionals. 
  Southern Heath Area Education Center, Fayetteville, NC - 1/13/2015
• Early Improvement with augmentation for major depressive disorder: A fresh look at the evidence. 
  Qingdao, China - 1/25/2014
• Management of psychiatric comorbidity in substance use disorders. 
  Asheville, NC - 1/22/2014
• An integrated framework to managing chronic pain, mental illness and substance abuse. 
  Raleigh, NC - 1/17/2014
• Substance use disorders in DSM-5. Revisions and Rationale 
  Pune, India - 1/16/2014
• Effects of milnacipran on pain and sexual function and in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial. 
  Hollywood, FL - 1/16/2014
• Project Lazarus: Chronic pain initiative in North Carolina 
  Wilmington, NC, 2013; Durham, NC, 2014; Henderson, NC, 2014 - 1/14/2014
• Effects of milnacipran on neurocognition and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial. 
  New York, NY - 1/3/2014
• F-MRI changes in a randomized controlled trial of ondansetron-methylphenidate combination in stimulant dependence. 
  New York, NY - 1/3/2014
• Early improvement with vilazodone in adults with major depressive disorder. A post-hoc analysis of a randomized, double-blind, placebo-controlled trial. 
  New York, NY - 1/3/2014
• Three Different Dose Initiation Strategies With Vilazodone In Major Depressive Disorder: A 8-Week Randomized, Double-Blind Trial Comparing Safety And Tolerability Of S... 
  New York, NY - 1/3/2014
• Lisdexamphetamine dimesylate augmentation in major depressive disorder: Post hoc item analysis of residual symptoms on the QIDS-SR in clinician rated remitters and non... 
  Hollywood, FL - 1/28/2013
• Milnacipran, neurocognition and fatigue in fibromyalgia: A double blind, randomized 13-week crossover trial. 
  San Francisco, CA - 1/18/2013
• Posthoc analysis of lisdexamphetamine dimesylate augmentation therapy effects on sleep related endpoints in adults with major depressive disorder. 
  San Francisco, CA - 1/18/2013
• Lisdexamphetamine dimesylate augmentation in anxious or nonanxious major depressive disorder. 
  San Francisco, CA - 1/18/2013
• Lisdexamphetamine dimesylate augmentation effects on executive function in major depressive disorder based on level of executive function impairment. 
  San Francisco, CA - 1/16/2013
• Screening and Brief Interventions for Substance Abuse 
  Multiple Locations, 2011, 2013 - 1/12/2013
• Mitigating Misuse and Abuse of Prescription Stimulants 
  Asheville, NC - 1/12/2013
• Chronic pain initiative in North Carolina 
  Gastonia, NC - 1/10/2013
• A proof-of-concept bench-to-bedside project. 
  Seoul, Republic of Korea - 1/6/2013
• Join now to see all

Other

• Opioid Use disorder 
  Patkar, A.A., Lee, J.C., Burgess, D.M., Disease State Management. Epocrates online. Athena Health, BMJ Publishing group
  London, United Kingdom - 1/1/2012